United States · FDA National Drug Code directory
Elrexfio
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63539-252_e5f013ba-4382-4ce2-8650-2ce23a5aaa5b
- Product NDC
- 63539-252
- Form
- INJECTION, SOLUTION
- Composition / generic term
- elranatamab-bcmm
- Labeler
- U.S. Pharmaceuticals
- Marketing category
- BLA
- Marketing start / end (source format)
- 20230815
- Source listing expiry
- 20271231
Source-listed ingredients
- ELRANATAMAB — 44 mg/1.1mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (63539-252-02) / 1.1 mL in 1 VIAL, SINGLE-DOSE (63539-252-01) · 63539-252-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →